false
0000816956
0000816956
2025-07-07
2025-07-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 7, 2025
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-39218 |
|
16-0977505 |
(State or other jurisdiction of
incorporation or organization) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
11311
Concept Blvd
Largo, FL |
|
33773 |
| (Address of principal executive offices) |
|
(Zip code) |
(727)
392-6464
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2
below):
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Rule 12(b) of
the Act
| Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
| Common Stock, $0.01 par value |
|
CNMD |
|
NYSE |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory. |
On July 7, 2025, CONMED Corporation (the “Company”)
announced that independent director Martha Aronson resigned from the Company’s Board of Directors effective as of July 7, 2025.
There were no disagreements between the Company and Ms. Aronson, who is resigning to assume a leadership role at another organization.
| Item 7.01 |
Regulation FD Disclosure. |
A copy of the press release
issued by the Company on July 7, 2025 announcing Ms. Aronson’s resignation is furnished with this Current Report on Form 8-K as
Exhibit 99.1.
The information furnished herewith pursuant to
Item 7.01 of this Current Report on Form 8-K shall not be deemed to be “filed” for purpose of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall
not be incorporated by reference into any registration statement or other document under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in such filing.
| Item 9.01 |
Financial Statements and Exhibits. |
| 99.1 |
|
Press Release, dated July 7, 2025, issued by CONMED Corporation. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: July 7, 2025 |
CONMED CORPORATION |
| |
(Registrant) |
| |
|
| |
|
| |
By: |
/s/ Todd W. Garner |
| |
Name: |
Todd W. Garner |
| |
Title: |
Executive Vice President, Finance and Chief Financial Officer |
